Advancing vaccine adjuvant research for tuberculosis
Active Definitive Contract Awarded Last action
- Contract number
- 75N93022C00041
- Awardee
-
University Of Sydney UEI CRPQN9NU7X28
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,143,902
Award facts
- Opportunity
-
- Advancing vaccine adjuvant research for tuberculosis Pre-Solicitation · BAADAIT75N93021R00008 · Posted Apr 12, 2021
- Contract value 100% obligated
- $14,143,902.00 Current and potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Australia
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $3,179,426 | |
| Change Order | $2,000,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $2,891,723 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $3,619,193 | |
| Original award | $2,453,560 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $14.14 million definitive contract to University Of Sydney for advancing vaccine adjuvant research for tuberculosis, with an ultimate completion date of September 29, 2027, under cost no-fee pricing and awarded September 30, 2022.
The originating solicitation, posted April 12, 2021, sought side-by-side comparisons of adjuvants in combination with tuberculosis immunogens to establish immunological profiles and further TB vaccine development. The contract was anticipated to have a five-year period of performance beginning July 22, 2022, with an average annual total cost of $4 million. NAICS code 541715 and PSC code R425 apply.
Place of performance is Australia. Government-invoiced labor in FY2024 totaled $2.2 million across 12.4 FTEs and 25,899 contractor hours at a derived rate of $86.52 per hour; FY2025 invoiced labor reached $3.2 million across 11.2 FTEs and 23,245 hours at $137.90 per hour, reflecting a rising cost trend. In FY2025, five subcontractors performed 44 percent of contractor hours.
Quick answers
Who was awarded contract 75N93022C00041?
75N93022C00041 was awarded to University Of Sydney by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2022.
How much is contract 75N93022C00041 worth?
The government has obligated $14,143,902 on 75N93022C00041.
Was contract 75N93022C00041 competed?
The extent of competition for 75N93022C00041 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award